281 related articles for article (PubMed ID: 10933928)
21. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection.
Schroers R; Davis CM; Wagner HJ; Chen SY
Gene Ther; 2002 Jul; 9(13):889-97. PubMed ID: 12080383
[TBL] [Abstract][Full Text] [Related]
23. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
24. Transduction of CD34+ cells by a vesicular stomach virus protein G (VSV-G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells.
Li X; Mukai T; Young D; Frankel S; Law P; Wong-Staal F
J Hum Virol; 1998; 1(5):346-52. PubMed ID: 10195262
[TBL] [Abstract][Full Text] [Related]
25. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
26. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE
Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110
[TBL] [Abstract][Full Text] [Related]
27. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
Berger G; Goujon C; Darlix JL; Cimarelli A
Gene Ther; 2009 Jan; 16(1):159-63. PubMed ID: 18668143
[TBL] [Abstract][Full Text] [Related]
28. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells.
Aicher A; Westermann J; Cayeux S; Willimsky G; Daemen K; Blankenstein T; Uckert W; Dörken B; Pezzutto A
Exp Hematol; 1997 Jan; 25(1):39-44. PubMed ID: 8989905
[TBL] [Abstract][Full Text] [Related]
29. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
30. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
31. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
32. Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells.
Evans JT; Cravens P; Gatlin J; Kelly PF; Lipsky PE; Garcia JV
Gene Ther; 2001 Sep; 8(18):1427-35. PubMed ID: 11571583
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral vector-mediated genetic programming of mouse and human dendritic cells.
Stripecke R
Methods Mol Biol; 2009; 506():139-58. PubMed ID: 19110625
[TBL] [Abstract][Full Text] [Related]
34. Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation.
Géronimi F; Richard E; Redonnet-Vernhet I; Lamrissi-Garcia I; Lalanne M; Ged C; Moreau-Gaudry F; De Verneuil H
Stem Cells; 2003; 21(4):472-80. PubMed ID: 12832700
[TBL] [Abstract][Full Text] [Related]
35. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
[TBL] [Abstract][Full Text] [Related]
36. Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells.
Akiyama Y; Maruyama K; Watanabe M; Yamaguchi K
Int J Oncol; 2002 Sep; 21(3):509-14. PubMed ID: 12168093
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
Kahl CA; Pollok K; Haneline LS; Cornetta K
Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944
[TBL] [Abstract][Full Text] [Related]
38. Gene delivery into primary cerebral cortical neurons by lentiviral vector.
Zhang Y; Wang H; Pan H; Bao X; Li M; Jin J; Wu X
Cell Biol Int; 2006 Oct; 30(10):777-83. PubMed ID: 16872845
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral vector gene transfer into human T cells.
Verhoeyen E; Costa C; Cosset FL
Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
[TBL] [Abstract][Full Text] [Related]
40. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
